Showing 2 posts of 2 posts found.


FDA approves Aurinia’s oral lupus nephritis therapy

January 26, 2021
Manufacturing and Production Aurinia

The FDA has approved Aurinia Pharmaceuticals’ LUPKYNIS (voclosporin) in combination with a background immunosuppressive therapy regimen to treat adult patients …

13 deaths in Aurinia’s lupus drug trial despite hitting Phase II target

August 16, 2016
Manufacturing and Production, Research and Development Aurinia, Phase II, biotech, patient deaths, voclosporin

Canadian biotech Aurinia Pharmaceuticals has announced the topline Phase IIb trial results of its lupus nephritis (LN) treatment voclosporin, which …

Latest content